Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin M Stroebel

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Neuroscience Letters|December 3, 2014
Intranasal deferoxamine engages multiple pathways to decrease memory loss in the APP/PS1 model of amyloid accumulationJared M Fine, Daniel B Renner, Anna C Forsberg, et al.
Neuroscience Letters|October 20, 2019
Intranasal delivery of low-dose insulin ameliorates motor dysfunction and dopaminergic cell death in a 6-OHDA rat model of Parkinson's DiseaseJared M Fine, Benjamin M Stroebel, Katherine A Faltesek, et al.
Frontiers in Neuroscience|January 28, 2025
Low-dose intranasal deferoxamine modulates memory, neuroinflammation, and the neuronal transcriptome in the streptozotocin rodent model of Alzheimer's diseaseJared M Fine, Jacob Kosyakovsky, Tate T Bowe, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Neuroscience Letters|December 3, 2014
Intranasal deferoxamine engages multiple pathways to decrease memory loss in the APP/PS1 model of amyloid accumulationJared M Fine, Daniel B Renner, Anna C Forsberg, et al.
Neuroscience Letters|October 20, 2019
Intranasal delivery of low-dose insulin ameliorates motor dysfunction and dopaminergic cell death in a 6-OHDA rat model of Parkinson's DiseaseJared M Fine, Benjamin M Stroebel, Katherine A Faltesek, et al.
Frontiers in Neuroscience|January 28, 2025
Low-dose intranasal deferoxamine modulates memory, neuroinflammation, and the neuronal transcriptome in the streptozotocin rodent model of Alzheimer's diseaseJared M Fine, Jacob Kosyakovsky, Tate T Bowe, et al.
Pageof 2